Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Lemtrada Safety Issues Lead To Use Restrictions In Europe

November 26, 2019 By Law Offices of Thomas J. Lamb, P.A.

Drug safety regulators for the European Union recently recommended that Lemtrada use be restricted to certain limited patient populations due to serious side effects linked to Lemtrada. This November 5, 2019 Multiple Sclerosis News Today report, “EMA Safety Group Advises Lemtrada Be Limited to ‘Highly Active’ RRMS Patients at Hospitals … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding disorders, bleeding in the lungs, Heart Attacks, Hepatitis, Lemtrada, liver damage, Strokes

Warnings About Significant Liver Injury Added To Tecfidera Drug Label

February 10, 2017 By Law Offices of Thomas J. Lamb, P.A.

In January 2017 liver injury was added to the Warnings and Precautions part of the Prescribing Information document, or drug label, for Tecfidera (dimethyl fumarate), which was approved by the FDA in 2013 as a treatment of patients with relapsing forms of multiple sclerosis (MS). We get background information and some commentary from this … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury, drug side effects, Hepatitis, Hepatotoxicity, liver damage, liver injury, Tecfidera

Risk of Hepatitis B Reactivation Associated With Gleevec And Iclusig

October 12, 2016 By Law Offices of Thomas J. Lamb, P.A.

Currently available medicines in the BCR-ABL TKIs class of drugs include Gleevec and Iclusig, as well as Tasigna, Bosulif, and Sprycel. These BCR-ABL tyrosine kinase inhibitors (TKIs) are used for the treatment of specific types of blood cancers, including Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) and Ph+ acute … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bosulif, Gleevec, Hepatitis, Iclusig, Sprycel, Tasigna

Black-Box Warning For Harvoni, Sovaldi, Viekira Pak: Hepatitis B Risk

October 7, 2016 By Law Offices of Thomas J. Lamb, P.A.

Direct-acting antivirals (DAAs) are a class of prescription medicines that are FDA-approved to treat adults with hepatitis C virus (HCV) infection. These medicines are available as single-ingredient products and also in combination with other HCV medicines. Here is a list of direct-acting antivirals currently available in the US: Daklinza … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Daklinza, Epclusa, Harvoni, Hepatitis, Olysio, Sovaldi, Technivie, Viekira Pak, Zepatier

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.